Table 1.
Pathogens associated with infections caused in the study population
| Total (n = 33) | Group A (n = 5) | Group B (n = 21) | Group C (n = 7) | MIC breakpoints (mg/L) | |
|---|---|---|---|---|---|
| Microbiological isolate, n (%) | |||||
| Enterococcus avium | 1 (3) | 0 | 1 (4.8) | 0 | 0.12 |
| Enterococcus faecalis | 3 (9.1) | 2 (40) | 1 (4.8) | 0 | 0.12 |
| Enterococcus faecium | 11 (33.3) | 4 (80) | 7 (33.3) | 0 | 0.12 |
| Escherichia coli | 4 (12.1) | 2 (40) | 2 (9.5) | 0 | 0.5 |
| MRSA | 1 (3) | 0 | 0 | 1 (14.3) | 0.25 |
| Staphylococcus epidermidis | 2 (6.1) | 0 | 3 (14.3) | 1 (14.3) | 0.12 |
| VRE | 9 (27.3) | 2 (40) | 3 (14.3) | 4 (57.1) | 0.12 |
| ESBL | 10 (30.3) | 3 (60) | 4 (19) | 3 (42.9) | 0.5 |
MRSA: methicillin-resistant Staphylococcus aureus; VRE: vancomycin-resistant Enterococci; ESBL: extended betalactamase producing Gram-negative bacteria; MIC: minimum inhibitory concentration